Select your country or region to view content specific to your country.
Anyplex™Ⅱ HPV28 Detection simultaneously detects, differentiates and quantifies 28 distinct HPV genotypes (19 high-risk and 9 low-risk) responsible for cervical cancer and/or sexually transmitted infections. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this multiplex assay performs on real-time PCR instrument and provides high sensitivity and specificity genotyping information of infected 28 HPV types in a single reaction
Detection and identification of 19 high-risk HPV and 9 low-risk HPV in a single reaction
Convenient workflow using Seegene’s automated one platform
Quantitative analysis by cyclic-CMTA
Utilization of the UDG system to prevent carry-over contamination
Multiplex real-time PCR with high sensitivity and specificity by utilization of DPO™ and TOCE™ technologies
Automated data interpretation and LIS interlocking with Seegene Viewer
Assistant of appropriate treatment and management for co-infection
Whole process validation from extraction to PCR by whole process control
Useful tool for surveillance and infection control
The result represents co-infection that HPV 16 is high (+++) in the HEX channel, HPV 52 is high(+++) in the Cal Red 610 channel, HPV 35, 61 are high (+++) in the Quasar 670 channel and HPV 40 is intermediate (++) in the Quasar 705 channel .
- Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions
- Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.
- Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities